s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Thursday, August 13, 2020
Accession number
0001493152-20-015417
Documents
form425.htm
425
ex99-1.htm
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header